A new class of drugs created to prevent migraine attacks came on the scene in 2018, and experts now recommend them as a preferred or “first line” treatment. Fremanezumab-vfrm (Ajovy) is one of these ...
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults
AJOVY® is the first and only subcutaneous anti-CGRP treatment with both quarterly (every three months) and monthly dosing options using either the autoinjector or prefilled syringe for the preventive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback